Search Results

Sensorion a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, announces the appointment of Ms Laurene Danon as Chief Financial Officer.

Sensorion a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, announces its participation in various investor conferences taking place in June 2024.

Sensorion announces that promising new data and analysis results from the SENS-401 following cochlear implantation Phase 2a clinical study will be presented at the 17th International Conference on Cochlear Implants and Other Implantable Technologies taking place on July 10-13, 2024, in Vancouver, Canada.

Sensorion announces that the Company’s shareholders are invited to participate in the Combined General Meeting, to be held on Wednesday, May 29, 2024, at 2pm CET in the premises of the hotel Square Louvois, located at 12, rue de Louvois, 75002, Paris, France.

Sensorion announces that it is publishing its Full Year 2023 Financial Report, which has been filed with the Autorité des marchés financiers.

Sensorion a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, announces the publication of the March 2024 Letter to Shareholders.

Sensorion a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, announces its participation in the Van Lanschot Kempen’s Life Sciences Conference, taking place on April 16 and 17, 2024, in Amsterdam, Netherlands.

Sensorion a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, announces its participation in the 27th Annual American Society of Cell and Gene Therapy Meeting, taking place on May 7-11, 2024, in Baltimore, United States of America.

Sensorion a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent hearing loss disorders, reports full-year 2023 financial results and business update.

Sensorion a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, announces its participation in the Bioprocessing Summit Europe, taking place on March 19-21, 2024, in Barcelona, Spain.